Abstract
(See the editorial commentary by Meddings and Saint, on pages 1291-1293.)Background.Foley catheter (FC) use is a modifiable risk factor for hospital-acquired urinary tract infection, the most common type of nosocomial infection. It is unknown whether sustained, hospital-wide reductions in FC use are achievable by combining interventions with demonstrated short-term effectiveness in selected units. Methods .A multifaceted quality improvement project to decrease unnecessary FC use and increase order documentation was instituted throughout the Minneapolis Veterans Affairs Medical Center in March 2005, after a >2-year baseline period. Bundled interventions included multiple types of education, system redesign, rewards, and feedback (phases I and II), plus, in phase III, involvement of a dedicated FC nurse. Results .The daily prevalence of FC use dropped steeply during intervention phase I (5.5 months), from a 15.2% baseline mean to a 9.3% nadir, but rebounded quickly during the subsequent hiatus phase (1.2 months). It dropped again (mean, 13.6%) during intervention phase II (27.3 months) and even further (mean, 12.0%) during intervention phase III (22.8 months) (P ≤. 001, phase II or III vs baseline). Compared with baseline, during phase III (with the dedicated FC nurse) the mean daily percentages of nonordered and nonindicated FCs dropped from 17% to 5.1% and from 15% to 1.2%, respectively. During phases II and III combined, an estimated total of 6691 FC days were avoided. Conclusion s.Significant hospital-wide reductions in total and inappropriate FC use and improved FC order documentation were achieved through a multicomponent campaign. The greatest and most sustained improvements accompanied the involvement of a dedicated FC nurse.
Original language | English (US) |
---|---|
Pages (from-to) | 1283-1290 |
Number of pages | 8 |
Journal | Clinical Infectious Diseases |
Volume | 52 |
Issue number | 11 |
DOIs | |
State | Published - Jun 1 2011 |
Bibliographical note
Funding Information:Dave Prentiss (MVAMC) prepared the figures. Financial support. This material is based on work supported by the Office of Research and Development, Medical Research Service, Department of Veterans Affairs (J. R. J.). Potential conflicts of interest. J. R. J. has received grants and/or consultancies from Bayer, Merck, Ortho-McNeil, Procter and Gamble, Rochester Medical, and Wyeth-Ayerst. All other authors: no conflicts.